FDA Advisory Committee Votes Unanimously in Favor of Plazomicin for Adults with cUTIs
May 3rd 2018However, the FDA's Drug Advisory Committee did not feel that there was substantial evidence regarding the safety and effectiveness of plazomicin for the treatment of bloodstream infections in patients with limited or no treatment options.
Read More
Risk of Adverse Pregnancy Outcomes with TDF-FTC-ATV/r Similar or Lower Than Other ART Regimens
April 26th 2018A recent study finds no difference in risk for adverse birth outcomes between 3 antiretroviral regimens taken by pregnant women with HIV, including TDF-FTC-LPV/r, a regimen that has raised safety concerns in a past trial.
Read More
Exploring the Best Treatment Option for Initial C. diff Infection In Pediatric Patients
April 20th 2018Dr. Thomas Sandora shares recent data on screening for asymptomatic carriage of Clostridium difficile and provides insight into what the preferred first-line treatment for the infection in children.
Read More